Asian Stocks Set to Track US Gains as Virus Treatment Hopes Lift Confidence

A top US health official said Gilead Sciences Inc's antiviral drug remdesivir is likely to become the standard of care for Covid-19 after early results from a clinical trial showed it helped certain patients recover more quickly.

from Top Business News- News18.com https://ift.tt/2VPt5SR

• Tweet
• Share
• Share
• Share
• Share